These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 10379624

  • 1. Modulation of behaviour on trials 1 and 2 in the elevated plus-maze test of anxiety after systemic and hippocampal administration of nicotine.
    Ouagazzal AM, Kenny PJ, File SE.
    Psychopharmacology (Berl); 1999 May; 144(1):54-60. PubMed ID: 10379624
    [Abstract] [Full Text] [Related]

  • 2. Conditioned anxiety to nicotine.
    File SE, Cheeta S, Irvine EE, Tucci S, Akthar M.
    Psychopharmacology (Berl); 2002 Nov; 164(3):309-17. PubMed ID: 12424555
    [Abstract] [Full Text] [Related]

  • 3. Tolerance to nicotine's effects in the elevated plus-maze and increased anxiety during withdrawal.
    Irvine EE, Cheeta S, File SE.
    Pharmacol Biochem Behav; 2001 Feb; 68(2):319-25. PubMed ID: 11267637
    [Abstract] [Full Text] [Related]

  • 4. Effect of intra-amygdala injection of nicotine and GABA receptor agents on anxiety-like behaviour in rats.
    Zarrindast MR, Solati J, Oryan S, Parivar K.
    Pharmacology; 2008 Feb; 82(4):276-84. PubMed ID: 18849647
    [Abstract] [Full Text] [Related]

  • 5. Neurobiological mechanisms by which nicotine mediates different types of anxiety.
    File SE, Cheeta S, Kenny PJ.
    Eur J Pharmacol; 2000 Mar 30; 393(1-3):231-6. PubMed ID: 10771018
    [Abstract] [Full Text] [Related]

  • 6. Anxiety conditioned to nicotine in the elevated plus-maze is time dependent.
    Tucci S, Cheeta S, Genn RF, Seth P, File SE.
    Behav Pharmacol; 2002 Dec 30; 13(8):615-20. PubMed ID: 12478211
    [Abstract] [Full Text] [Related]

  • 7. Social isolation modifies nicotine's effects in animal tests of anxiety.
    Cheeta S, Irvine E, File SE.
    Br J Pharmacol; 2001 Apr 30; 132(7):1389-95. PubMed ID: 11264231
    [Abstract] [Full Text] [Related]

  • 8. Hippocampal and septal injections of nicotine and 8-OH-DPAT distinguish among different animal tests of anxiety.
    Cheeta S, Kenny PJ, File SE.
    Prog Neuropsychopharmacol Biol Psychiatry; 2000 Oct 30; 24(7):1053-67. PubMed ID: 11131172
    [Abstract] [Full Text] [Related]

  • 9. Methyllycaconitine (MLA) blocks the nicotine evoked anxiogenic effect and 5-HT release in the dorsal hippocampus: possible role of alpha7 receptors.
    Tucci SA, Genn RF, File SE.
    Neuropharmacology; 2003 Mar 30; 44(3):367-73. PubMed ID: 12604094
    [Abstract] [Full Text] [Related]

  • 10. Role of the medial septum cholinoceptors in anxiogenic-like effects of nicotine.
    Zarrindast MR, Tajik R, Ebrahimi-Ghiri M, Nasehi M, Rezayof A.
    Physiol Behav; 2013 Jul 02; 119():103-9. PubMed ID: 23769693
    [Abstract] [Full Text] [Related]

  • 11. The effects of nicotine on nitric oxide induced anxiogenic-like behaviors in the dorsal hippocampus.
    Piri M, Nasehi M, Shahab Z, Zarrindast MR.
    Neurosci Lett; 2012 Oct 24; 528(2):93-8. PubMed ID: 22985517
    [Abstract] [Full Text] [Related]

  • 12. Role of ventral hippocampal GABA(A) and NMDA receptors in the anxiolytic effect of carbamazepine in rats using the elevated plus maze test.
    Rezvanfard M, Zarrindast MR, Bina P.
    Pharmacology; 2009 Oct 24; 84(6):356-66. PubMed ID: 19907194
    [Abstract] [Full Text] [Related]

  • 13. The role of the dorsal hippocampal serotonergic and cholinergic systems in the modulation of anxiety.
    File SE, Kenny PJ, Cheeta S.
    Pharmacol Biochem Behav; 2000 May 24; 66(1):65-72. PubMed ID: 10837844
    [Abstract] [Full Text] [Related]

  • 14. Effects of co-administration of bupropion and nicotinic agonists on the elevated plus-maze test in mice.
    Carrasco MC, Vicens P, Vidal J, Redolat R.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 May 24; 30(3):455-62. PubMed ID: 16413646
    [Abstract] [Full Text] [Related]

  • 15. The anxiogenic-like effect of caffeine in two experimental procedures measuring anxiety in the mouse is not shared by selective A(2A) adenosine receptor antagonists.
    El Yacoubi M, Ledent C, Parmentier M, Costentin J, Vaugeois JM.
    Psychopharmacology (Berl); 2000 Feb 24; 148(2):153-63. PubMed ID: 10663430
    [Abstract] [Full Text] [Related]

  • 16. Effects of nicotine and a cannabinoid receptor agonist on negative contrast: distinction between anxiety and disappointment?
    Genn RF, Tucci S, Parikh S, File SE.
    Psychopharmacology (Berl); 2004 Dec 24; 177(1-2):93-9. PubMed ID: 15205871
    [Abstract] [Full Text] [Related]

  • 17. Modulatory effects of the basolateral amygdala α2-adrenoceptors on nicotine-induced anxiogenic-like behaviours of rats in the elevated plus maze.
    Bashiri H, Rezayof A, Sahebgharani M, Tavangar SM, Zarrindast MR.
    Neuropharmacology; 2016 Jun 24; 105():478-486. PubMed ID: 26878830
    [Abstract] [Full Text] [Related]

  • 18. Anxiogenic profile of AM-251, a selective cannabinoid CB1 receptor antagonist, in plus-maze-naïve and plus-maze-experienced mice.
    Rodgers RJ, Evans PM, Murphy A.
    Behav Pharmacol; 2005 Sep 24; 16(5-6):405-13. PubMed ID: 16148445
    [Abstract] [Full Text] [Related]

  • 19. Infralimbic kappa opioid and muscarinic M1 receptor interactions in the concurrent modulation of anxiety and memory.
    Wall PM, Messier C.
    Psychopharmacology (Berl); 2002 Mar 24; 160(3):233-44. PubMed ID: 11889492
    [Abstract] [Full Text] [Related]

  • 20. Anxiogenic effects in the rat elevated plus-maze of 5-HT(2C) agonists into ventral but not dorsal hippocampus.
    Alves SH, Pinheiro G, Motta V, Landeira-Fernandez J, Cruz AP.
    Behav Pharmacol; 2004 Feb 24; 15(1):37-43. PubMed ID: 15075625
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.